Cureline Team
Cureline management team is well known and respected among members of the scientific community. We are committed to providing the highest quality consulting, project management and study support, which will help you to achieve your research program goals.
Our clinical team includes a group of highly motivated and well trained medical doctors, medical assistants, lab techs, and general support members. Their familiarity with clinical settings allows for the successful implementation and execution of custom designed projects.
At Cureline we strive to be involved in the clinical research and development process. Our experience and knowledge allows us to be an ideal partner for your scientific programs.
Olga Potapova, PhD
Founder
CEO and Scientific Director
Olga Potapova is an expert in biotechnology, life sciences business development and international alliance management.
Since 2003, Dr. Potapova leads Cureline a group of companies working in the area of translational medicine research and laboratory services. Previously she worked in the fields of cancer research (NIH and Pfizer/SUGEN), human molecular genetics and genomics, oncology drug R&D and translational medicine.
Olga has advanced degrees in Physics and Biochemistry and received multiple AACR/AFLAC awards, NIH and NATO fellowships.
Warren Dodge
Senior Vice President, Strategic Accounts
Warren Dodge has extensive experience in the oncology services market with more than 21 years experience in the healthcare industry and 30 years experience growing early-stage businesses.
Alexander M. Lituev, MD
Vice President, Biospecimen Operations
Dr. Lituev has been developing multi-national Clinical Network and Cureline Biorepository since 2004.
Previously he was a Clinical Director and Business Development manager for an independent clinic in St. Petersburg (Russia).
Dr. Lituev has seven years of clinical practice experience and medical certification in Intensive care, Anesthesiology, Neurology and Acupuncture. Currently he leads Cureline Biospecimen Operations including database development, biospecimen management and Quality Assurance.
Kathleen Talmadge
Vice President, Finance and Operations
Ms. Talmadge has been an entrepreneur and a business manager for over 25 years. At Cureline Kathleen oversees project management and finance activities of the company.
Prior to joining Cureline in 2005, she was instrumental in setting up and managing companies in the high-end retail, hospitality and service maintenance industries. She brings to the Cureline team her extensive experience in finance, accounting, purchasing and contract negotiations.
Kathleen holds a B.S. in Economics degree from Assumption College (Makati, Philippines).
Irina A. Zaytseva, MBA
Vice President, Business Development
Ms. Zaytseva has over 14 years of business experience in biotechnology and marketing.
Prior to joining Cureline in 2009, Irina was a founder and CEO of RuNovel Group, a business advisory firm providing executive management services to technology entrepreneurs and advising small companies on business development strategies and fundraising. In the past, she has provided executive management, marketing and corporate strategy services to US and Russia based companies (IRMEP, Johnson and Johnson, Align Technology).
Her industry experience includes therapeutics, instrumentation, and medical devices.
Dmitry V. Belyaev, MD
Executive Director (Russia)
Director, Regulatory Affairs
Dmitry Belyaev has participated in the clinical research industry in Eastern Europe since the early 1990s. Dmitry oversees Cureline's activities in Russia and is responsible for protocol reviews and regulatory submissions.
Dmitry has a broad clinical research experience in a number of therapeutic areas, including Psychiatry, Oncology, Pediatrics, Cardiology, and Immunology. Dmitry is an expert in Quality Assurance, GCP/GLP, and regulatory affairs for medicines and medical devices in the Russian Federation. He was also involved in the design and management of preclinical animal studies, and was a Deputy Scientific Director of one of the first biotechnology companies in Russia.
Dmitry Belyaev received an M.D. from the Pavlov Medical Academy (St. Petersburg, Russia), and holds clinical certificates in Emergency Medicine and Psychiatry.
Olga V. Voronina, PhD
Co-Founder
Director, Strategic Alliances
Dr. Voronina is a co-Founder of Cureline Inc., and has an extensive experience in international biomedical project negotiation and management.
Since 2001 she has been leading the acquisition and archiving of donated human tissue specimens for drug discovery and development, and successfully developed the Cureline Clinical Site Network.
Previously, for more than twenty years, Dr. Voronina provided leadership in scientific research program development for the Russian Academy of Medical Sciences, and has successfully developed small businesses in both Russia and the USA.
